These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 146928)

  • 1. [Study on hematological toxicity in irradiation and ICRF 159 combination treatment during experimentation on animals with particular consideration of long-term effects (author's transl)].
    Hassenstein E; Renner K
    Strahlentherapie; 1978 Feb; 154(2):122-6. PubMed ID: 146928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies in mice treated with ICRF-159 combined with daunorubicin or doxorubicin.
    Giuliani F; Casazza AM; Di Marco A; Savi G
    Cancer Treat Rep; 1981; 65(3-4):267-76. PubMed ID: 6263470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of ICRF-187 by 48-hour continuous infusion.
    Koeller JM; Earhart RH; Davis HL
    Cancer Treat Rep; 1981; 65(5-6):459-63. PubMed ID: 6786740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of ICRF-187 against normal tissue injury induced by adriamycin in combination with whole body hyperthermia.
    Baba H; Stephens LC; Strebel FR; Siddik ZH; Newman RA; Ohno S; Bull JM
    Cancer Res; 1991 Jul; 51(13):3568-77. PubMed ID: 1905199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Animal experiments on the toxicity of tumoricidal agents].
    Hassenstein E; Renner K; Bendel V; Wolf R
    Strahlentherapie Sonderb; 1978; 75():171-6. PubMed ID: 555046
    [No Abstract]   [Full Text] [Related]  

  • 6. Preclinical toxicologic evaluation of ICRF-187 in dogs.
    Levine BS; Henry MC; Port CD; Rosen E
    Cancer Treat Rep; 1980; 64(12):1211-5. PubMed ID: 6781745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recovery of erythrocytes, leukocytes and thrombocytes after the termination of continuous radiation].
    Macková N; Praslicka M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(6):878-84. PubMed ID: 6162753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of ICRF-187 using a daily for 3 days schedule.
    Von Hoff DD; Howser D; Lewis BJ; Holcenberg J; Weiss RB; Young RC
    Cancer Treat Rep; 1981; 65(3-4):249-52. PubMed ID: 6786738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow regeneration in germfree NO-2 mice after 700 rad whole body irradiation.
    Heit H; Fliedner TM; Fache I
    Radiat Res; 1972 Jul; 51(1):72-83. PubMed ID: 5037619
    [No Abstract]   [Full Text] [Related]  

  • 10. ICRF-187 in clinical oncology.
    Poster DS; Penta JS; Bruno S; Macdonald JS
    Cancer Clin Trials; 1981; 4(2):143-6. PubMed ID: 6788388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of treatments with a quinine-lithium-salicylate combination or acetylsalicylic acid on hematopoiesis in mice (author's transl)].
    Hrsak I; Szirmai E
    Arzneimittelforschung; 1979; 29(1):44-8. PubMed ID: 582117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP).
    Orsolić N; Basić I
    Biomed Pharmacother; 2005 Dec; 59(10):561-70. PubMed ID: 16202559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the L isomer (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4566-76. PubMed ID: 6171341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of the effect of rubomycin C and B on peripheral blood of animals].
    Vertogradova TP
    Antibiotiki; 1969 Sep; 14(9):840-5. PubMed ID: 5361829
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiapoptotic cytokines in combination with pegfilgrastim soon after irradiation mitigates myelosuppression in nonhuman primates exposed to high irradiation dose.
    Hérodin F; Roy L; Grenier N; Delaunay C; Baugé S; Vaurijoux A; Grégoire E; Martin C; Alonso A; Mayol JF; Drouet M
    Exp Hematol; 2007 Aug; 35(8):1172-81. PubMed ID: 17560010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of ICRF-159 in refractory metastatic breast cancer.
    Creech RH; Engstrom PF; Harris DT; Catalano RB; Bellet RE
    Cancer Treat Rep; 1979 Jan; 63(1):111-4. PubMed ID: 369681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of rubomycin C on the blood system in experimental conditions].
    Gol'dberg DI; Kraìushkina NP; Antipov IG
    Antibiotiki; 1971 Mar; 16(3):240-3. PubMed ID: 5558685
    [No Abstract]   [Full Text] [Related]  

  • 19. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologic effects of recombinant human interleukin-6 in dogs exposed to a total-body radiation dose of 2.4 Gy.
    Selig C; Kreja L; Müller H; Seifried E; Nothdurft W
    Exp Hematol; 1994 Jul; 22(7):551-8. PubMed ID: 8013570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.